NCT07944209
Remimazolam Induction Methods in Robotic Cholecystectomy
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Emergence time
Timeframe: From discontinuation of sevoflurane until MOAA/S score 5; assessed within 10 minutes.
Secondary (10)
Time to loss of responsiveness
Total remimazolam dose
Post-anesthesia care unit (PACU) stay duration
Postoperative pain score in PACU
Rescue analgesic doses in PACU
Show 5 moreShow less
Postoperative nausea and vomiting and rescue antiemetic use
Respiratory depression
Hemodynamic instability
Modified Aldrete score at PACU admission
Rescue flumazenil administration
Arms and interventions
Single-Bolus Remimazolam InductionActive comparator
Remimazolam 0.2 mg/kg administered as a single intravenous bolus for anesthetic induction.
Continuous-Infusion Remimazolam InductionExperimental
Remimazolam administered by continuous intravenous infusion at 12 mg/kg/hour for anesthetic induction.
Drugs: Remimazolam
Sites
1 site in 1 country
- Korea University Ansan HospitalAnsan, Gyeonggi-do, South Korea